UDG Healthcare plc (UDG) Downgraded to “Reduce” at Numis Securities Ltd
Numis Securities Ltd downgraded shares of UDG Healthcare plc (LON:UDG) to a reduce rating in a research note published on Thursday morning. The brokerage currently has GBX 765 ($10.06) price target on the stock.
A number of other research firms also recently weighed in on UDG. Liberum Capital restated a buy rating and issued a GBX 930 ($12.23) price target on shares of UDG Healthcare plc in a research note on Wednesday, July 12th. Peel Hunt lifted their price objective on shares of UDG Healthcare plc from GBX 840 ($11.05) to GBX 860 ($11.31) and gave the company an add rating in a research note on Tuesday, October 31st. Jefferies Group LLC boosted their price target on shares of UDG Healthcare plc from GBX 830 ($10.92) to GBX 855 ($11.25) and gave the company a hold rating in a research note on Wednesday, October 4th. Finally, N+1 Singer boosted their price target on shares of UDG Healthcare plc from GBX 770 ($10.13) to GBX 841 ($11.06) and gave the company a hold rating in a research note on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of GBX 825.71 ($10.86).
UDG Healthcare plc (LON UDG) opened at GBX 899.50 ($11.83) on Thursday. UDG Healthcare plc has a 1 year low of GBX 612 ($8.05) and a 1 year high of GBX 963 ($12.67).
TRADEMARK VIOLATION NOTICE: This report was reported by Daily Political and is owned by of Daily Political. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/11/13/udg-healthcare-plc-udg-downgraded-to-reduce-at-numis-securities-ltd.html.
About UDG Healthcare plc
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.